La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Body and Mind Résultats passés
Passé contrôle des critères 0/6
Body and Mind's earnings have been declining at an average annual rate of -44.2%, while the Pharmaceuticals industry saw earnings declining at 0.2% annually. Revenues have been growing at an average rate of 25.1% per year.
Informations clés
-44.2%
Taux de croissance des bénéfices
-35.5%
Taux de croissance du BPA
Pharmaceuticals Croissance de l'industrie | 6.0% |
Taux de croissance des recettes | 25.1% |
Rendement des fonds propres | n/a |
Marge nette | -98.3% |
Dernière mise à jour des bénéfices | 30 Apr 2024 |
Mises à jour récentes des performances passées
Recent updates
Ventilation des recettes et des dépenses
Comment Body and Mind gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Apr 24 | 23 | -23 | 8 | 0 |
31 Jan 24 | 23 | -16 | 8 | 0 |
31 Oct 23 | 22 | -17 | 9 | 0 |
31 Jul 23 | 23 | -21 | 8 | 0 |
30 Apr 23 | 13 | -29 | 7 | 0 |
31 Jan 23 | 17 | -29 | 7 | 0 |
31 Oct 22 | 20 | -30 | 7 | 0 |
31 Jul 22 | 23 | -29 | 7 | 0 |
30 Apr 22 | 32 | -6 | 7 | 0 |
31 Jan 22 | 31 | -4 | 7 | 0 |
31 Oct 21 | 29 | -2 | 7 | 0 |
31 Jul 21 | 27 | -2 | 7 | 0 |
30 Apr 21 | 20 | -3 | 7 | 0 |
31 Jan 21 | 14 | -4 | 6 | 0 |
31 Oct 20 | 9 | -4 | 6 | 0 |
31 Jul 20 | 5 | -4 | 6 | 0 |
30 Apr 20 | 5 | -5 | 5 | 0 |
31 Jan 20 | 5 | -4 | 4 | 0 |
31 Oct 19 | 5 | -4 | 4 | 0 |
31 Jul 19 | 5 | -4 | 4 | 0 |
30 Apr 19 | 4 | -2 | 3 | 0 |
31 Jan 19 | 4 | -2 | 3 | 0 |
31 Oct 18 | 4 | -2 | 2 | 0 |
31 Jul 18 | 2 | -2 | 2 | 0 |
30 Apr 18 | 1 | -2 | 2 | 0 |
31 Jan 18 | 1 | -2 | 2 | 0 |
31 Oct 17 | 0 | -1 | 1 | 0 |
31 Jul 17 | 0 | 0 | 0 | 0 |
30 Apr 17 | 0 | 0 | 0 | 0 |
31 Jan 17 | 0 | 0 | 0 | 0 |
31 Oct 16 | 0 | 0 | 0 | 0 |
31 Jul 16 | 0 | 0 | 0 | 0 |
30 Apr 16 | 0 | 0 | 0 | 0 |
31 Jan 16 | 0 | 0 | 0 | 0 |
31 Oct 15 | 0 | 0 | 0 | 0 |
31 Jul 15 | 0 | 0 | 0 | 0 |
30 Apr 15 | 0 | 0 | 0 | 0 |
31 Jan 15 | 0 | 0 | 0 | 0 |
31 Oct 14 | 0 | 0 | 0 | 0 |
31 Jul 14 | 0 | 0 | 0 | 0 |
30 Apr 14 | 0 | 0 | 0 | 0 |
31 Jan 14 | 0 | 0 | 0 | 0 |
Des revenus de qualité: BMMJ is currently unprofitable.
Augmentation de la marge bénéficiaire: BMMJ is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: BMMJ is unprofitable, and losses have increased over the past 5 years at a rate of 44.2% per year.
Accélération de la croissance: Unable to compare BMMJ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: BMMJ is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (13%).
Rendement des fonds propres
ROE élevé: BMMJ's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.